Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Case Reports in Hematology|July 27, 2019
Case of a CD3 Negative Hepatosplenic T-Cell Lymphoma: Diagnostic and Therapeutic ChallengesLaura Alder, Scott Graupner, Guanhua Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2026
Broadening clinical trial inclusivity of patients with lung cancer and brain metastases utilizing the Graded Prognostic Assessment (GPA): A call to actionLaura Alder, Trey C Mullikin, Chris Lascola, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|May 30, 2019
Testicular Swelling as an Initial Presentation of a Patient With Metastatic Gastric CancerLaura Alder, Taha Al-Juhaishi, Steven C Smith, et al.
Clinical Advances in Hematology & Oncology : H&O|May 17, 2022
Systemic management of brain metastases in HER2+ breast cancer in 2022Laura Alder, Sarah Sammons, Amanda E D Van Swearingen, et al.
Ochsner Journal|April 6, 2016
Initial Match Rates of an Innovative International Partnership: The Ochsner Clinical School ExperienceRichard E Deichmann, Laura Alder, Leonardo Seoane, et al.
Cancers|July 12, 2025
Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future PerspectivesDiamone Gathers, Cameron Oswalt, Laura Alder, et al.
Journal of Gastrointestinal Oncology|July 12, 2023
Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinomaHannah M Lee, Laura Alder, Matthew Nguyen, et al.
Neuro-Oncology Advances|April 29, 2024
Unique genomic alterations in the circulating tumor DNA of patients with solid tumors brain metastasesLaura Alder, Gloria Broadwater, Michelle Green, et al.
JCO Precision Oncology|October 31, 2022
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine TherapySarah Sammons, Kira Raskina, Natalie Danziger, et al.
Breast Cancer Research and Treatment|November 20, 2022
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancerLaura Noteware, Gloria Broadwater, Nicole Dalal, et al.
Pageof 2